top of page
Medex EU Authorised Representative logo

EU Authorized Representative for Catheter Manufacturers: Rules 5 to 8, Central Circulatory System and the Mandate

Catheters span every class in Regulation (EU) 2017/745. A transient urinary catheter is class I under Rule 5 of Annex VIII, a peripheral cannula is class IIa under Rule 7, and a central venous or cardiovascular catheter is class III because it touches the central circulatory system. For every class, a manufacturer established outside the Union must designate a sole authorized representative under Article 11, and one mandate covers the EU and Türkiye.

Route of entry, duration and anatomy decide the class

A catheter can enter through a natural opening or through the skin, and it can stay for minutes, days or months. A urinary catheter enters through a body orifice and is not surgically invasive; a vascular catheter is surgically invasive under Section 2.2 of Annex VIII:

"a device which produces penetration other than through a body orifice." (MDR Annex VIII, Section 2.2(b))

Urinary and other body-orifice catheters: Rule 5

"All invasive devices with respect to body orifices, other than surgically invasive devices, which are not intended for connection to an active device or which are intended for connection to a class I active device are classified as:" (MDR Annex VIII, Rule 5)

  • "class I if they are intended for transient use;"
  • "class IIb if they are intended for long-term use, except if they are used in the oral cavity as far as the pharynx, in an ear canal up to the ear drum or in the nasal cavity and are not liable to be absorbed by the mucous membrane, in which case they are classified as class IIa."

The second indent places short-term use in class IIa. MDCG 2021-24 lists urinary catheters for transient use as class I, indwelling urinary catheters for short term use as class IIa and urinary catheters for long term use as class IIb. Suction catheters connected to an active suction device are class IIa under the second paragraph of the rule.

Vascular catheters: Rules 6, 7 and 8 and the central circulatory system

"‘Central circulatory system’ means the following blood vessels: arteriae pulmonales, aorta ascendens, arcus aortae, aorta descendens to the bifurcatio aortae, arteriae coronariae, arteria carotis communis, arteria carotis externa, arteria carotis interna, arteriae cerebrales, truncus brachiocephalicus, venae cordis, venae pulmonales, vena cava superior and vena cava inferior." (MDR Annex VIII, Section 2.6)

A catheter used for less than 60 minutes falls under Rule 6:

"All surgically invasive devices intended for transient use are classified as class IIa unless they:" (MDR Annex VIII, Rule 6)

  • "are intended specifically to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with those parts of the body, in which case they are classified as class III;"

MDCG 2021-24 places catheters used outside the central circulatory system in class IIa and angioplasty balloon catheters in class III. A catheter left in place for between 60 minutes and 30 days falls under Rule 7:

"All surgically invasive devices intended for short-term use are classified as class IIa unless they:" (MDR Annex VIII, Rule 7)

  • "are intended specifically for use in direct contact with the heart or central circulatory system or the central nervous system, in which case they are classified as class III;"

MDCG 2021-24 lists infusion cannulae as class IIa, central venous catheters, PICC lines and neurological catheters as class III, and temporary dialysis catheters as class IIb under the indent on administering medicines. A catheter intended for more than 30 days falls under Rule 8, which starts from class IIb and uses the same central circulatory system indent for class III: peripheral vascular catheters for long-term use are listed as class IIb, central vascular catheters for long-term use as class III.

Is a long-term catheter an implant?

"Any device intended to be partially introduced into the human body by clinical intervention and intended to remain in place after the procedure for at least 30 days shall also be deemed to be an implantable device;" (MDR Article 2(5))

MDCG 2021-24 gives the infusion port placed to remain for at least 30 days as an implant, and a non-tunnelled central venous catheter for temporary vascular access as not an implant. A tunnelled catheter or port intended to remain for more than 30 days therefore carries the implant card under Article 18, the summary of safety and clinical performance under Article 32 and the 15-year retention period of Article 10(8).

Coatings move the class: Rules 14 and 19

"All devices incorporating, as an integral part, a substance which, if used separately, can be considered to be a medicinal product, as defined in point 2 of Article 1 of Directive 2001/83/EC, including a medicinal product derived from human blood or human plasma, as defined in point 10 of Article 1 of that Directive, and that has an action ancillary to that of the devices, are classified as class III." (MDR Annex VIII, Rule 14)

MDCG 2021-24 lists catheters coated with anticoagulants such as heparin as class III under Rule 14. Where a coating is a nanomaterial, Rule 19 applies; an intravascular catheter with a nano-coating is listed as class III.

Classification table for a catheter range

Product variantClassRuleNotified body
Intermittent urinary catheter, transientI (sterile)Rule 5, first indentLimited to sterility
Peripheral catheter, transient, outside the central circulatory systemIIaRule 6Yes
Angioplasty balloon catheter, stent delivery catheterIIIRule 6, first indentYes
Peripheral infusion cannula, short termIIaRule 7Yes
Central venous catheter, PICC line, neurological catheterIIIRule 7, central circulatory or nervous system indentsYes
Peripheral vascular catheter for long-term useIIbRule 8Yes; implant obligations if it remains 30 days or more
Central vascular catheter for long-term use, tunnelledIIIRule 8, second indentYes
Catheter with a heparin coatingIIIRule 14Yes

Conformity assessment for class III catheters

"Manufacturers of class III devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Annex IX. Alternatively, the manufacturer may choose to apply a conformity assessment as specified in Annex X coupled with a conformity assessment as specified in Annex XI." (MDR Article 52(3))

Where the class III catheter is also implantable, Article 54 adds the clinical evaluation consultation procedure. Class IIa and IIb catheters follow Article 52(6) and 52(4) at the notified body.

What the authorized representative mandate covers for catheters

The appointment turns on where the manufacturer is established, not on the class of the device:

"Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative." (MDR Article 11(1))

Article 11(3) fixes the minimum tasks:

"The mandate shall require, and the manufacturer shall enable, the authorised representative to perform at least the following tasks in relation to the devices that it covers:" (MDR Article 11(3))

  • "verify that the EU declaration of conformity and technical documentation have been drawn up and, where applicable, that an appropriate conformity assessment procedure has been carried out by the manufacturer;"
  • "immediately inform the manufacturer about complaints and reports from healthcare professionals, patients and users about suspected incidents related to a device for which they have been designated;"

A catheter portfolio spans several generic device groups; Article 11(2) requires the mandate to cover at least all devices of each group (see sole authorized representative per generic device group).

One mandate for the European Union and Türkiye

Medex Kurumsal Danışmanlık acts as EU authorized representative under EUDAMED SRN TR-AR-000057550, with offices in Ankara and İstanbul. A manufacturer of catheters established outside the EU and Türkiye does not need two representatives:

"manufacturers established outside the territory of the EU or Turkey only need to designate one authorised representative, either in the EU or in Turkey, in order to place medical devices on the market in the EU or in Turkey." (European Commission, Notice to Stakeholders, EU-Turkey Customs Union Agreement in the field of medical devices, March 2022, section I.2)

"The ’Union market’ refers to the territories of the European Union Member States, and due to the European Economic Area (EEA) is extended to Norway, Lichtenstein and Iceland, and via the Customs Union Agreement to Turkey." (MDCG 2022-16, footnote 1)

Our mandate covers the EU Member States and Türkiye; we are not a Swiss representative or UK Responsible Person, not a notified body, and we do not find importers or distributors. The published bands on our pricing page are €800 to 1,000 per year for class I, €1,000 to 1,300 per year for class IIa, €1,500 to 2,000 per year for class III, with a €0 setup fee and rates fixed for three years from signature. Registration of the same catheters in ÜTS (Ürün Takip Sistemi), Türkiye's product tracking system, is a separate service: ÜTS registration of catheters in Türkiye (Turkish).

The symbol that identifies the representative on your label is explained in our guide to the EC REP meaning. If some devices are still placed on the market under the former directives, see the authorized representative for legacy devices.

Related device categories and country pages

Related groups: infusion sets, stents, syringes and needles. All groups are listed on the medical device categories page, and the manufacturer country pages start from the EU authorized representative by country list.

Frequently asked questions

Which class is an intermittent urinary catheter?

Class I. It is invasive with respect to a body orifice, not surgically invasive, and intended for transient use, so the first indent of Rule 5 applies; MDCG 2021-24 lists it as a class I example.

Why is a central venous catheter class III when a peripheral cannula is class IIa?

Both are short-term surgically invasive devices under Rule 7. The rule moves a device to class III where it is intended for direct contact with the central circulatory system, which Section 2.6 defines by listing the vessels, including the vena cava. A peripheral cannula does not reach them.

Is a tunnelled long-term catheter an implantable device?

If it is intended to remain in place for at least 30 days after the procedure, Article 2(5) deems the partially introduced device implantable. MDCG 2021-24 gives the infusion port as an implant and the temporary non-tunnelled central venous catheter as not one.

What does a heparin coating do to the class?

Rule 14 places a device incorporating a substance that would be a medicinal product if used separately, with an ancillary action, in class III. MDCG 2021-24 lists catheters coated with anticoagulants such as heparin as an example.

Does one mandate cover the European Union and Türkiye?

Yes. The European Commission's Notice of March 2022 confirms that a manufacturer established outside the EU and Türkiye needs only one authorized representative, established in the EU or in Türkiye. Medex is established in Türkiye under EUDAMED SRN TR-AR-000057550.

Sources and further reading

Regulation (EU) 2017/745 on medical devices (MDR), Articles 2, 10, 11, 18, 32, 52 and 54, Annex VIII - eur-lex.europa.eu

MDCG 2021-24, Guidance on classification of medical devices (October 2021) - health.ec.europa.eu

MDCG 2022-16, Guidance on authorised representatives (Regulation (EU) 2017/745 and Regulation (EU) 2017/746) - health.ec.europa.eu

European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices (March 2022) - health.ec.europa.eu

Get a fixed-price EU REP quote for your catheter range (reply within 1 business day).

Request a proposal  ·  View pricing  ·  Our EU REP service

bottom of page